IMC-A12

{
  "id": "MLC-T-ONC-004183",
  "term": "IMC-A12",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. It is a monoclonal antibody that is made in the laboratory and can bind to substances in the body. IMC-A12 blocks the action of a protein needed for cell growth and may kill cancer cells. It is a type of insulin-like growth factor-1 receptor (IGF-1R) inhibitor. Also called cixutumumab.",
  "expansions": [
    "cixutumumab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/imc-a12/"
}